Bausch & Lomb BLCO
NYSE BLCO
$17.24 +0.04 (+0.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch & Lomb (BLCO) Income from Non-Controlling Interests (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Income from Non-Controlling Interests came in at $4.0 million in Q2 2026, little changed YoY from $4.0 million in Q2 2025, and up 300.0% on a QoQ basis from $1.0 million in Q1 2026.

Bausch & Lomb (BLCO) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has 6 years of Income from Non-Controlling Interests data on file, last reported at $4.0 million in Q2 2026.

  • Quarterly Income from Non-Controlling Interests changed 0.0% year-over-year to $4.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.0 million (down 20.0% YoY) and the FY2025 annual result came in at $8.0 million, down 33.33% from the prior year.
  • Income from Non-Controlling Interests improved to $4.0 million in Q2 2026, from $1.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $4.0 million in Q3 2023 to a low of $1.0 million in Q4 2022.
  • A 5-year average of $2.7 million and a median of $3.0 million in 2022 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests surged 200.0% — and 2025, when it sank 75.0%.
  • Tracing BLCO's Income from Non-Controlling Interests over 5 years: stood at $1.0 million in 2022, then surged by 200.0% to $3.0 million in 2023, then slumped by 66.67% to $1.0 million in 2024, then surged by 200.0% to $3.0 million in 2025, then jumped by 33.33% to $4.0 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at $4.0 million (Q2 2026), $1.0 million (Q1 2026), and $3.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 6.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 79.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Bausch & Lomb 6.14 Bn 5.76 Bn 867.00 Mn 4.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.00 Mn
Mar 31, 2026 1.00 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 4.00 Mn
Mar 31, 2025 1.00 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 4.00 Mn
Jun 30, 2024 3.00 Mn
Mar 31, 2024 4.00 Mn
Dec 31, 2023 3.00 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 3.00 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 1.00 Mn
Sep 30, 2022 3.00 Mn
Jun 30, 2022 2.00 Mn
Mar 31, 2022 3.00 Mn
Dec 31, 2021 3.00 Mn
Sep 30, 2021 3.00 Mn
Jun 30, 2021 2.00 Mn